Treatment of a patient with multifocal atherosclerosis and severe aortic stenosis

Zemlyanskaya O.A.; Panchenko E.P.; Arutunyan G.K.; Balakhonova T.V.; Kushnir V.V.

doi:https://doi.org/10.17116/Cardiobulletin20211604181

Zemlyanskaya O.A.

National Medical Research Center of Cardiology

Panchenko E.P.

National Medical Research Center of Cardiology

Arutunyan G.K.

National Medical Research Center of Cardiology

Balakhonova T.V.

National Medical Research Center of Cardiology

Kushnir V.V.

National Medical Research Center of Cardiology

Treatment of a patient with multifocal atherosclerosis and severe aortic stenosis

Authors:

Zemlyanskaya O.A., Panchenko E.P., Arutunyan G.K., Balakhonova T.V., Kushnir V.V.

More about the authors

Journal: Russian Cardiology Bulletin. 2021;16(4): 81‑88

DOI: 10.17116/Cardiobulletin20211604181

Read: 7789 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Zemlyanskaya OA, Panchenko EP, Arutunyan GK, Balakhonova TV, Kushnir VV. Treatment of a patient with multifocal atherosclerosis and severe aortic stenosis. Russian Cardiology Bulletin. 2021;16(4):81‑88. (In Russ.)
https://doi.org/10.17116/Cardiobulletin20211604181

Подписка 2026 Кардиологический вестник (Russian Cardiology Bulletin)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Quality of life within 6 months after coronary artery bypass grafting. Russian Cardiology Bulletin. 2025;(3):62-71

Surgical treatment of a patient with severe aortic stenosis and hereditary factor XI deficiency. Russian Cardiology Bulletin. 2025;(4):88-93

Immediate results of coronary bypass grafting without touching the aorta in patients with multiple-vessel disease: a single-center retrospective study. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(3):280-285

Intraoperative myocardial infarction or reperfusion syndrome? Features of ECG diagnostics. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):428-433

Meta-analysis on the relevance of septal myectomy in aortic valve replacement. Pirogov Russian Journal of Surgery. 2025;(10-2):94-99

Measurement and analysis of intraventricular turbulent blood flow and kinetic energy in patients with aortic stenosis. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(6):651-656

Complex surgical treatment of critical aortic stenosis complicated by multiple organ failure. Pirogov Russian Journal of Surgery. 2025;(12):162-167

Distal protection in transcatheter aortic valve implantation: pros and cons. Choice of the patient or preferences of the clinic and surgeon?. Pirogov Russian Journal of Surgery. 2025;(11-2):12-19

Antiembolic cerebral protection in transcatheter aortic valve implantation: from large evidence-based data to clinical case. Pirogov Russian Journal of Surgery. 2025;(11-2):90-96

Vector mapping of blood flow in the left ventricle in healthy and patients with aortic stenosis. Russian Journal of Cardiology and Cardiovascular Surgery. 2026;(1):57-61

Abstract:

Currently, optimal treatment strategy in patients with multifocal atherosclerosis is still an urgent problem. This is due to the lack of a clear algorithm for choosing between surgical, endovascular and hybrid treatment, as well as certain difficulties in determining the sequence of their implementation. This report is devoted to treatment of a patient with severe aortic stenosis and atherosclerotic lesions of several arterial pools, vascular complications and multiple risk factors for unfavorable course of atherosclerosis.

Keywords:

multifocal atherosclerosis

aortic stenosis

transcatheter aortic valve implantation

coronary artery bypass surgery

carotid artery stenting

Authors:

Zemlyanskaya O.A.

National Medical Research Center of Cardiology

Panchenko E.P.

National Medical Research Center of Cardiology

Arutunyan G.K.

National Medical Research Center of Cardiology

Balakhonova T.V.

National Medical Research Center of Cardiology

Kushnir V.V.

National Medical Research Center of Cardiology

Received:

23.11.2021

Accepted:

24.11.2021

Close metadata

References:

Steg PG, Bhatt DL, Wilson PW, D’Agostino R Sr, Ohman EM, Röther J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S; REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297(11):1197-1206. https://doi.org/10.1001/jama.297.11.1197
Hennerici M, Aulich A, Sandmann W, Freund H. Incidence of asymptomatic extracranial arterial disease. Stroke. 1981;12(6):750-758. https://doi.org/10.1161/01.str.12.6.750
Ciccone M, Di Noia D, Di Michele L, Corriero F, Di Biase M, Biasco MG, Novo S, Strano A, Rizzon P. The incidence of asymptomatic extracoronary atherosclerosis in patients with coronary atherosclerosis. International Angiology. 1993;12(1):25-28.
Naylor A, Bown M. Stroke after cardiac surgery and its association with asymptomatic carotid disease: an updated systematic review and meta-analysis. European Journal of Vascular and Endovascular Surgery. 2011;41(5):607-624. https://doi.org/10.1016/j.ejvs.2011.02.016
Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, Bajwa T, Heiser JC, Merhi W, Kleiman NS, Askew J, Sorajja P, Rovin J, Chetcuti SJ, Adams DH, Teirstein PS, Zorn GL 3rd, Forrest JK, Tchétché D, Resar J, Walton A, Piazza N, Ramlawi B, Robinson N, Petrossian G, Gleason TG, Oh JK, Boulware MJ, Qiao H, Mugglin AS, Reardon MJ; Evolut Low Risk Trial Investigators. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. The New England Journal of Medicine. 2019;380(18):1706-1715. https://doi.org/10.1056/NEJMoa1816885
Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, Kapadia SR, Malaisrie SC, Cohen DJ, Pibarot P, Leipsic J, Hahn RT, Blanke P, Williams MR, McCabe JM, Brown DL, Babaliaros V, Goldman S, Szeto WY, Genereux P, Pershad A, Pocock SJ, Alu MC, Webb JG, Smith CR; PARTNER 3 Investigators. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. The New England Journal of Medicine. 2019;380(18):1695-1705. https://doi.org/10.1056/NEJMoa1814052.
Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O’Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A, Toly C. 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):72-227. https://doi.org/10.1161/CIR.0000000000000923
Komarov AL, Novikova ES, Guskova EV, Yarovaya EB, Samko AN, Panchenko EP. New Possibilities of Antithrombotic Therapy of Patients with Peripheral and Widespread Atherosclerotic Lesion. Racional’naya farmakoterapiya v kardiologii. 2018;14(2):272-283. (In Russ.). https://doi.org/10.20996/1819-6446-2018-14-2-272-283
Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Maggioni AP, Lopez-Jaramillo P, O’Donnell M, Kakkar AK, Fox KAA, Parkhomenko AN, Ertl G, Störk S, Keltai M, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim J-H, Tonkin AM, Lewis BS, Felix C, Yusoff K, Steg PG, Metsarinne KP, Bruns NC, Misselwitz F, Chen E, Leong D, and Yusuf S, for the COMPASS Investigators. https://doi.org/10.1056/NEJMoa1709118
Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal. 2020;41(3):407-477. https://doi.org/10.1093/eurheartj/ehz425
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O; ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Heart Journal. 2020;41(1):111-188. https://doi.org/10.1093/eurheartj/ehz455
Nacional’nye rekomendacii po diagnostike i lecheniyu zabolevanij arterij nizhnih konechnostej. Accessed October 25, 2021. (In Russ.). https://www.angiolsurgery.org/library/recommendations/2019/recommendations_LLA_2019.pdf
Aboyans V, Bauersachs R, Mazzolai L, Brodmann M, Palomares JFR, Debus S, Collet JP, Drexel H, Espinola-Klein C, Lewis BS, Roffi M, Sibbing D, Sillesen H, Stabile E, Schlager O, De Carlo M. Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy. European Heart Journal. 2021;42(39):4013-4024. https://doi.org/10.1093/eurheartj/ehab390
Ten Berg J, Sibbing D, Rocca B, Van Belle E, Chevalier B, Collet JP, Dudek D, Gilard M, Gorog DA, Grapsa J, Grove EL, Lancellotti P, Petronio AS, Rubboli A, Torracca L, Vilahur G, Witkowski A, Mehilli J. Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease. European Heart Journal. 2021;42(23):2265-2269. https://doi.org/10.1093/eurheartj/ehab196